AFLAC Incorporated · NYSE:AFL

AFLAC — Investor Presentation (June 2024)

38 slides from AFLAC's investor presentation, Jun 6, 2024

  1. Slide 1: Aflac Incorporated Investor Update

    Aflac Incorporated Investor Update June 6, 2024

  2. Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures

    Forward-Looking Statements and Non-GAAP Financial Measures The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meani

  3. Slide 3: Key Highlights

    Key Highlights 1 Leading provider of supplemental health insurance in the U.S. and Japan 2 Diversified and broad distribution supported by well-recognized and reputable brand Strong, consistent earnings generation backing the Company’s ability to service debt and 3 tactically deploy capital 4 Less c

  4. Slide 4: Aflac Incorporated Highlights

    Aflac Incorporated Highlights as of 12/31/2023 $18.7bn $7.4bn Adjusted Revenues Revenues Debt1 by Business $195mm $22.0bn Interest Expense2 Book Value $4.7bn 19.7% Aflac U.S. Net Earnings Adjusted Leverage* 37% Aflac Japan $3.7bn 13.8% 60% Adjusted Earnings* Adjusted ROE* a A- A3 A+ A+ Corporate & A

  5. Slide 5: Aflac Incorporated Financial Performance

    Aflac Incorporated Financial Performance In $ millions Consolidated Earnings Adjusted Leverage 4,778 4,659 33,398 34,011 34,658 4,418 35000 32,524 0.24 4,231 3,925 3,733 28,565 23.0% 22.7% 3,552 3,614 30000 0.23 3,304 3,314 25000 20.9% 0.22 20000 20.4% 19.7% 0.21 15000 10000 7,467 7,568 7,105 0.2 5,

  6. Slide 6: Aflac Incorporated's Long-Term Growth Strategy

    Aflac Incorporated’s Long-Term Growth Strategy Be there for our policyholders when they need us most 66

  7. Slide 7: Leveraging a Strong Brand in a Special Way

    Leveraging a Strong Brand in a Special Way1  $173 million donated by our employees, agents and brokers to the Aflac Cancer and Blood Disorders Center1  150,000+ patients and their families have received support through Aflac Parents House in Tokyo and Osaka2  27,066 My Special Aflac Ducks®3 that

  8. Slide 8: Aflac Japan Segment

    Aflac Japan Segment 5C/ Anniversary

  9. Slide 9: Japan Insurance Market Size and Penetration

    Japan Insurance Market Size and Penetration Insurance Market Size Insurance Product Penetration, (Number of policies in force) 100.0% Individual Basis 45 (in millions) 40 80.0% 35 72.1% 73.1% 30 66.8% 60.0% 25 42.6% 41.9% 20 37.8% 40.0% 15 10 20.0% 12.3% 10.4% 9.9% 5 9.1% 6.3% 0 0.0% 2020 2021 2022

  10. Slide 10: Japan Insurance Products: Third Sector Leader

    Aflac Japan Insurance Products: Third Sector Leader • Simple product design that appeals to younger policyholders with basic needs #1 provider Medical and older or existing policyholders who desire additional or updated coverage • Launched mid-September 2023 of cancer and • Provides coverage for the

  11. Slide 11: Reaching More Customers through Diverse Distribution

    Reaching More Customers through Diverse Distribution: Being Where People Want to Purchase Protection Traditional Core • Vital for Aflac Japan sales, with nearly 7,000 agencies Channel • Japan Post Co., has more than 20,000 post offices nationwide selling Aflac Japan Post cancer insurance products Gr

  12. Slide 12: Japan Financials Update

    Aflac Japan Financials Update Aflac Japan Net Earned Premiums Pretax Adjusted Earnings and by Product Pretax Profit Margin1 (¥mm) ¥500,000 ¥430,823 ¥456,859 35% Third Sector ¥411,808 ¥400,000 ¥354,802 ¥347,881 30% ¥300,000 30.5% 27.7% 25% ¥200,000 26.1% Medical and 20% ¥100,000 21.3% 21.2% other hea

  13. Slide 13: Aflac U.S. Segment

    Aflac U.S. Segment

  14. Slide 14: Leader in U.S. Worksite Supplemental Health Insurance

    Leader in U.S. Worksite Supplemental Health Insurance1 U.S. Worksite Supplemental Health Insurance Sales Market Share2 Aflac U.S. maintains its market leadership and expects to grow as we execute our strategy with a robust product portfolio that meets customer needs • Critical Care (Incl. Cancer) Af

  15. Slide 15: U.S. Growth Opportunities

    Aflac U.S. Growth Opportunities U.S. Working Population1 Solving for Access, Penetration & Retention 161.2 Million 16.7M Self-Employed 16.7M D2C Public Sector 21.7M 111.2M 33.3M Private Sector 122.8M Aflac is Not Employer 7.5M2 25.8M Offered by Access to Aflac Have Aflac Do Not Employer Have Aflac P

  16. Slide 16: U.S. Financials Update

    Aflac U.S. Financials Update Net Earned Premiums Pretax Adjusted Earnings and as of 12/31/2023 Pretax Profit Margin1 ($mm) $2,000 25% Critical care $1,501 30.7% $1,500 $1,272 $1,268 $1,356 $1,359 23% 22.7% 21% $1,000 20.9% 21.0% 19% $500 19.4% 19.3% 17% Hospital indemnity $0 15% 12.7% 2019 2020 2021

  17. Slide 17: 1st Quarter 2024 Results

    1 Quarter 2024 Results st

  18. Slide 18: Japan 1Q24

    Aflac Japan 1Q24: Favorable experience, good expense control and very strong margin Benefit Ratio % Expense Ratio % Pretax Profit Margin % 32.8 68 21 31 67 2024 Outlook Ranges YTD Actual Operating Ratios 66 19 29 18 18

  19. Slide 19: U.S. 1Q24

    Aflac U.S. 1Q24: Providing customers value, scaling growth and solid margin Benefit Ratio % Expense Ratio % Pretax Profit Margin % 47 40 21 21.0 46.5 38.7 2024 Outlook Ranges YTD Actual Operating Ratios 45 38 19 19

  20. Slide 20: 1Q24 – Another Solid Quarter

    1Q24 – Another Solid Quarter Net EPS Adjusted EPS* Adjusted EPS ex-FX* +67.5% $3.25 +7.1% +12.3% $1.66 $1.74 $1.55 $1.55 $1.94 1Q23 1Q24 1Q23 1Q24 1Q23 1Q24 *A non-US GAAP financial measure. See appendix for information about this measure. 20

  21. Slide 21: Strong ROE

    Strong ROE 33.0 23.8 14.2 13.7 1Q23 1Q24 ROE (%) Adjusted ROE (%)* *A non-US GAAP financial measure. See appendix for information about this measure. 21

  22. Slide 22: Investment Portfolio

    Investment Portfolio Afiac.

  23. Slide 23: Disciplined Asset Allocation and Credit Underwriting

    Disciplined Asset Allocation and Credit Underwriting As of 3/31/2024 Fixed Maturities: Asset Allocation Fixed Maturities: Quality Sector and Industry Gov't Ag 44.8% Banks/Fin 10.1% A 67.7% Pub Util 8.2% Cons NonCyc 6.8% 6.0% Tech 3.7% $100 billion Basics 2.5% 84.2% AUM 4.5% Transp 3.3% 1.6% Cap Good

  24. Slide 24: Commercial Real Estate Loan Portfolio

    Aflac Commercial Real Estate Loan Portfolio As of 3/31/2024 • Portfolio consists of first-lien senior secured loans $7.6bn 224 $38mm diversified by property type and location ~8% of Total Investment Portfolio Unique Issuers Average Loan Size o 21.5% longer-term commercial mortgages on stabilized pro

  25. Slide 25: Middle Market Loan Portfolio

    Aflac Middle Market Loan Portfolio As of 3/31/2024 $4.5bn 308 $16mm • Defensively underwritten and monitored first lien, ~4.5% of Total Investment senior secured floating rate portfolio with strong Unique Issuers Average Loan Size Portfolio covenants o 100% of loans secured by all assets of the borr

  26. Slide 26: Capital Management

    Capital Management 26

  27. Slide 27: Strong Capital Ratios

    Strong Capital Ratios ESR estimated to be slightly above 250%1 ALIJ Solvency Margin Ratio Aflac Combined Risk-Based Capital Ratio2 (Fiscal year ending March 31, %) (Fiscal year ending December 31, %) 1,200 1136 800 961 732 710 917 941 889 659 881 800 600 531 550 400 400 200 0 0 2019 2020 2021 2022 2

  28. Slide 28: Returning Capital to Shareholders

    Returning Capital to Shareholders 2023: 41st consecutive year of increasing the annual dividend and record $2.8 billion in share repurchase 1 +9% CAGR 2023 $3.8 billion $ 1Annualized first quarter dividend; dividends for second through fourth quarters of 2024 have not been declared and are subject t

  29. Slide 29: Capital Deployment under Stable Conditions

    Capital Deployment under Stable Conditions Tactical Capital Deployment1 ($ billions) Considerations $5.0 • Organic capital generation of $2.6 to $3 billion 4.0 • Aflac Re Bermuda potentially unlocks additional 3.0 deployable capital • January 2023 and 4Q23 transactions each 2.0 freed up ~$900 millio

  30. Slide 30: Strategic Strengths

    Strategic Strengths • Industry-leading market share and scale in Japan and U.S. • Recognized and powerful brand • Diverse and productive distribution • Product innovation and customized, high-quality service • Strong capital position ◦ Stable earnings ◦ Strong cash flows ◦ Tactical deployment • Afla

  31. Slide 31: Learn more: investors.aflac.com

    Learn more: investors.aflac.com Contact us: Aflac Incorporated Investor and Rating Agency Relations 1932 Wynnton Road Columbus, GA 31999 tel: 706.596.3264 or 800.235.2667 or 011.81.3.3344.0481 in Japan AflacIR@aflac.com

  32. Slide 32: Appendix

    Appendix Afiac. Incorporated

  33. Slide 33: Glossary of Non-U.S. GAAP and Other Measures

    Glossary of Non-U.S. GAAP and Other Measures The Company defines these non-U.S. GAAP financial measures as follows: • Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the we

  34. Slide 34: Glossary of Non-U.S. GAAP and Other Measures (cont'd)

    Glossary of Non-U.S. GAAP and Other Measures (cont’d) The Company defines these non-U.S. GAAP financial measures as follows: • Adjusted return on equity excluding foreign currency impact is adjusted earnings excluding the current period foreign currency impact divided by average shareholders’ equity

  35. Slide 35: Reconciliation of Net Earnings to Adjusted Earnings

    Reconciliation of Net Earnings to Adjusted Earnings1 Three months ended March 31 in millions of Dollars 2024 2023 % Change Net earnings $1,879 $1,188 58.2% Items impacting net earnings: Adjusted net investment (gains) losses (1,009) (209) Other and non-recurring (income) loss 2 — Income tax (benefit

  36. Slide 36: Reconciliation of Net Earnings Per Diluted Share to Adjusted Earnings Per Diluted Share

    Reconciliation of Net Earnings Per Diluted Share to Adjusted Earnings Per Diluted Share Three months ended March 31 2024 2023 % Change Net earnings per diluted share $3.25 $1.94 67.5% Items impacting net earnings: Adjusted net investment (gains) losses (1.75) (0.34) Other and non-recurring (income)

  37. Slide 37: Reconciliation of U.S. GAAP Book Value per Share

    Reconciliation of U.S. GAAP Book Value per Share1 Three Months Ended March 31, in millions of Dollars 2024 2023 %Change U.S. GAAP book value per common share $41.27 $32.65 26.4% Less: Unrealized foreign currency translation gains (losses) per common share (8.18) (5.97) Unrealized gains (losses) on s

  38. Slide 38: Adjusted Leverage Ratios

    Adjusted Leverage Ratios (In millions) 2024 2023 Notes Payable $7,912 $7,420 50% of subordinated debentures and perpetual bonds (295) (335) Pre-funding of debt maturities (198) — Adjusted debt1 7,420 7,086 Total Shareholders’ Equity 23,537 19,784 Accumulated other comprehensive (income)loss: Unreali

Aflac — Investor Presentation (June 2024) on 6ix